Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Elliott currently holds 234,618 shares of Sirtris Pharmaceuticals, Inc. (SIRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Elliott has been a net neutral trader of SIRT stock. They have purchased $0 and sold $0 worth of shares.
Peter Elliott's most recent insider trade was on May 27, 2008, when they sold 21,428 shares at $1.10 per share.
Peter Elliott serves as Executive at Sirtris Pharmaceuticals, Inc. (SIRT). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Peter Elliott holds the position of Executive at Sirtris Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Peter Elliott has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Elliott was on May 27, 2008, when they sold $31.2K worth of SIRT shares. This transaction involved 74,404 shares at $0.42 per share.
Peter Elliott currently owns 234,618 shares of Sirtris Pharmaceuticals, Inc. (SIRT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Elliott's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Elliott has 5 Form 4 filings on record as an insider at Sirtris Pharmaceuticals, Inc..
Set alerts for Peter Elliott and 40,000+ other insiders.